Search

Your search keyword '"Sabani Anna"' showing total 4 results
Start Over Author "Sabani Anna"
4 results on '"Sabani Anna"'

1. The impact of vaccination status on post-acute sequelae in hospitalized COVID-19 survivors using a multi-disciplinary approach: An observational single center study

Author

Lucia Ilaria Birtolo, Gianluca Di Pietro, Antonella Ciuffreda, Riccardo Improta, Sara Monosilio, Silvia Prosperi, Sara Cimino, Nicola Galea, Paolo Severino, Gioacchino Galardo, Maria Chiara Colaiacomo, Patrizia Pasculli, Angelo Petroianni, Paolo Palange, Claudio Maria Mastroianni, Laura de Vito, Carlo Catalano, Francesco Pugliese, Maria Rosa Ciardi, Paola Celli, Roberto Badagliacca, Francesco Fedele, Carmine Dario Vizza, Viviana Maestrini, Massimo Mancone, Agnes Gianluca, Albante Alida, Alfarano Maria, Araimo Morselli Fabio, Auricchio Daniela, Barletta Giovanna, Bilotta Federico, Brisciani Matteo, Bruno Katia, Bucarelli Maria Clelia, Cappannoli Alessandro, Ceccarelli Giancarlo, Celli Paola, Consolo Stella, Consoli Giulia, Croce Claudia, Crocitti Beatrice, D'Antoni Letizia, De Lazzaro Francesco, De Lauri Daniela, De Persis Francesca, De Rose Maria, Del Bianco Andrea, Di Bella Valerio, Di Sano Laura, Di Santo Carmela, Filomena Domenico, Giannetti Lorena, Giordano Giovanni, Ianni Stefano, Imperiale Carmela, Magnanimi Eugenia, Manganelli Chiara, Maldarelli Federica, Manzi Giovanna, Marcon Serena, Mariani Marco Valerio, Martelli Sabina, Messina Teresa, Neccia Matteo, Novelli Martina, Papa Silvia, Pasqualitto Fabiola, Pattelli Elisa, Pecorari Filippo, Perrella Serena, Passarelli Ilaria, Piazzolla Mario, Piro Agostino, Portieri Monica, Ratini Fabiola, Ricci Claudia, Romano Hilde, Sabani Anna, Santopietro Pietro, Tanzilli Alessandra, Tellan Guglielmo, Titi Luca, Tocci Marco, Tordiglione Paolo, Tosi Antonella, Trigilia Fausto, Verduci Noemi, and Vaccaro Paola

Subjects
Long-COVID19, mRNA vaccines, Hospitalized, Survivors, Sequalae, Science (General), Q1-390, Social sciences (General), H1-99
Abstract

Background: COVID-19 vaccines reduced mortality, hospitalizations and ICUs admissions. Conversely, the impact of vaccination on Long COVID-19 syndrome is still unclear. This study compared the prevalence of post-acute sequelae at short and long-term follow-up among hospitalized unvaccinated and vaccinated COVID-19 survivors through a multidisciplinary approach. Methods: After 2 months from discharge, unvaccinated and vaccinated COVID-19 survivors underwent a follow-up visit at a dedicated “post-COVID-19 Outpatient Clinic”. The follow-up visit included a cardiovascular evaluation, blood tests, chest computed tomography, 6-min walking test (6MWT), spirometry. A one-year telephone follow-up was performed to assess re-hospitalizations, death and long-lasting symptoms. An additional 1:1 case-control matching analysis adjusted for baseline characteristics was performed. Results: Between June 2020 and June 2022, a total of 458 unvaccinated and vaccinated patients (229 per group) underwent the follow-up visit. Vaccinated patients had lower rates of ICU admissions (1.7 % vs 9.6 %, p=

Published
2024
Full Text
View/download PDF

3. Cardiac involvement in consecutive unselected hospitalized COVID-19 population: in-hospital evaluation and one-year follow-up

Author

Bruno Katia, Nicola Galea, Barletta Giovanna, Maldarelli Federica, De Lauri Daniela, Pasqualitto Fabiola, Prosperi Silvia, Francesco Pugliese, Titi Luca, Lucia Ilaria Birtolo, Del Bianco Andrea, Albante Alida, Francesco Fedele, Cappannoli Alessandro, Imperiale Carmela, Giannetti Lorena, Gabriella d'Ettorre, Marco Francone, Messina Teresa, Claudio Maria Mastroianni, Perrella Serena, Consolo Stella, De Rose Maria, Petroianni Angelo, Magnanimi Eugenia, Romano Hilde, Celli Paola, De Lazzaro Francesco, Carlo Catalano, Giulia d'Amati, Tosi Antonella, Brisciani Matteo, Martelli Sabina, Di Bella Valerio, Maestrini Ilaria, Paolo Severino, Massimo Mancone, Alberto Deales, Piazzolla Mario, Bilotta Federico, Bucarelli Maria Clelia, Maria Chiara Colaiacomo, Ricci Claudia, Croce Claudia, Tellan Guglielmo, Gioacchino Galardo, Ceccarelli Giancarlo, Ianni Stefano, Cristina Chimenti, Novelli Martina, Pasculli Patrizia, Verduci Noemi, Tordiglione Paolo, Santopietro Pietro, Rachele Edoardo Sebastian, Araimo Morselli Fabio, Auricchio Daniela, Manganelli Chiara, Letizia D'Antoni, Ratini Fabiola, Paolo Palange, Portieri Monica, Viviana Maestrini, Giordano Giovanni, Francavilla Santi, Maria Rosa Ciardi, Di Sano Laura, Pecorari Filippo, Carlo Lavalle, Di Santo Carmela, Crocitti Beatrice, Vaccaro Paola, Franco Ruberto, Trigilia Fausto, D'Antoni Letizia, Pattelli Elisa, Consoli Giulia, Francesco Alessandri, Sabani Anna, and Giulia Cundari

Subjects
medicine.medical_specialty, education.field_of_study, COPD, business.industry, medicine.medical_treatment, Population, Percutaneous coronary intervention, 030204 cardiovascular system & hematology, medicine.disease, COVID-19, cardiovascular disease, cardiovascular magnetic resonance, echocardiography, follow-up, myocarditis, Coronary artery disease, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Heart failure, medicine, Medical history, cardiovascular diseases, 030212 general & internal medicine, Myocardial infarction, Cardiology and Cardiovascular Medicine, education, Prospective cohort study, business
Abstract

Background Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Methods Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard electrocardiogram (ECG), Troponin and echocardiography were integrated by further tests when indicated. Medical history, arterial blood gas, blood tests, chest computed tomography and treatment were recorded. CVD was defined as the occurrence of a new condition during the hospitalization for COVID-19. Survivors attended a one-month follow-up visit and a one-year telephone follow-up. Results Forty-two patients (28%) experienced a wide spectrum of CVD with acute myocarditis being the most frequent. Death occurred in 32 patients (21%) and more frequently in patients who developed CVD (p = 0.032). After adjustment for confounders, CVD was independently associated with death occurrence. At one-month follow-up visit, 7 patients (9%) presented persistent or delayed CVD. At one-year telephone follow-up, 57 patients (48%) reported persistent symptoms. Conclusion Cardiovascular evaluation in COVID-19 patients is crucial since the occurrence of CVD in hospitalized COVID-19 patients is common (28%), requires specific treatment and increases the risk of in-hospital mortality. Persistence or delayed presentation of CVD at 1-month (9%) and persistent symptoms at 1-year follow-up (48%) suggest the need for monitoring COVID-19 survivors.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results